Agencies
Proof Your Campaign Moved the Market, Not Just the Metrics
Agency measurement stops at the ad tech layer. Komodo picks it up in the data your client actually cares about. Prove lift on a control group defensible against review.
Impressions Were Never the Deliverable
Your client is measured on prescription behavior. You’re measured on impressions served. That gap is where agency relationships fray. Legacy panels miss specialty Rx. Ad tech attribution models nobody would defend in front of a biostatistician. The loop stays open every quarter. Komodo closes it.
The Data Your Ad Stack Doesn’t Have
Ad platforms see impressions. The Healthcare Map sees what happened next. It is the only foundation that captures both what was prescribed and who prescribed it, current enough to matter and complete enough to defend. That is why an NPI list becomes a lift analysis, not an estimate.
A Control Group Defensible Against Review
Deterministic. Reproducible. Built on the Healthcare Map, not a panel. You hand us an NPI list and exposure data. We construct the control cohort using opinionated defaults refined across thousands of analyses, join it to linked claims, and return exposed versus control Rx lift. Methodology, documented.
Target and Measure on the Same Data
Build the audience on the most complete view of Rx and clinical volume. Refresh weekly. Run the campaign. Measure lift against the same dataset the audience came from. One closed loop.
“Our clients are thrilled that we can finally measure the real impact of our campaigns. The power of Komodo to help us accurately predict true ROI is beyond anything else I’ve seen on the market.”
Account Director· Leading Pharma Agency
Your Client Is Measuring Rx, So Should You
Not a generic demo. A working session using an NPI list and exposure log you care about, scoped to your therapeutic area.